Archives

by in
Entry Author Date Location
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Third Quarter 10/28/11 Boston
Amgen Cuts 70 Washington Jobs, Hutch Spins Off Blaze Bioscience, Henney Enters the Hall, & More Seattle-Area Life Sciences News 10/20/11 Seattle
Amgen Confirms 380 Layoffs in R&D; Cuts Coming to Seattle, SF, Boston 10/19/11 National
Got Some Immunex Memorabilia in the Closet? Break it Out at the Immunex Impact Dec. 1 10/19/11 Seattle
NextBio Sees Growth in Next Market: Physicians Seeking Help Interpreting Individual Genomes 10/18/11 San Francisco
Amgen Mulls R&D Cuts, Thong Le Named WBBA Chairman, NanoString’s Version 2.0, & More Seattle-Area Life Sciences News 10/13/11 Seattle
Amgen Looking to Improve Focus and “Re-allocate Resources” for R&D, Say More Oct. 24 10/12/11 National
Merck Fine-Tunes Biosimilars Strategy as FDA Guidelines Loom 10/05/11 New York
Crescendo Bioscience Nabs $56M to Help Personalize Rheumatoid Arthritis Therapy 09/08/11 San Francisco
Fearless Fantasy Football, Uh, I Mean Biotech, Predictions for the Season Ahead 09/06/11 National
Jennerex Shows that Unorthodox Cancer-Fighting Virus Can be Delivered the Usual Way 08/31/11 San Francisco
Zymeworks Snags $187M Deal With Merck to Discover Multi-Pronged Antibodies 08/29/11 Seattle
Acceleron, Celgene Take Aim at Amgen’s Multibillion-Dollar Anemia Market 08/05/11 Boston
FDA Says It Will Review Affymax Drug 07/27/11 San Francisco
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent 07/18/11 National
Sanofi Collaboration Drives Regeneron’s Transformation From R&D House to Commercial Player 07/13/11 New York
Sorbent Therapeutics Seeks to Fight Heart Failure in Unusual Arena: The Gut 07/13/11 San Francisco
Sorbent Therapeutics Absorbs $36M to Go After New Treatment For Kidney, Heart Failure 06/30/11 San Francisco
Tesaro Snags Huge $101M Venture Round to Develop Cancer Drugs 06/21/11 Boston
The Quest For Biotech Independence: Maybe It Isn’t So Quixotic After All 06/06/11 National
Radius Raises $91 Million to Advance Osteoporosis Drug, Makes Strides Towards Public Listing 05/24/11 Boston
Jennerex Shows Survival Edge for Liver Cancer Patients in Small Study of Anti-Tumor Virus 05/19/11 San Francisco
Finding a Solution To Our Biotech Malaise Together 05/18/11 Seattle
The Resurgence of Gene and Cell Therapy 05/16/11 Seattle
SpringLeaf Snags $15M for New Self-Injection System for Biotech Drugs 05/12/11 Boston
Immune Design Gets New CEO, Seattle Biomed Nabs $9M, VCs Turn Up Heat on FDA, & More Seattle-Area Life Sciences News 04/28/11 Seattle
KEW, Led by Millennium Co-Founder, Seeks to Bring Big-Time Cancer Care to Community Clinics 04/27/11 Boston
SR One Opens Bay Area Shop 04/26/11 San Francisco
Ariad Extends Licenses, Amgen Osteoporosis Drug Meets Trial Goals, Corindus Partners with Philips, & More Boston-Area Life Sciences News 04/22/11 Boston
Amgen Passes Key Trial With “Son of Dmab” For Osteoporosis 04/21/11 National
Page 2 of 9 « previous page · next page »
    

Xconomy Events Across the Network

The Napa Summit: Keeping America Growing

San Francisco · 6/7/12

More Xconomy Events

Xconomy’s Most Popular

  1. ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
  2. Biotech IPOs Start to Show Some Modest Signs of Life
  3. Hey, Silicon Valley: Wake Up and Smell the Robots
  4. From MIT Entrepreneur to Tea Party Leader: The Thomas Massie Story
  5. Announcing Xconomy’s Napa Summit: Keeping America Growing

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.